Evidence map›Paper›PMID 37071335›Full record

ArticleAIDS and behavior2023

A Comparison of COVID-19 Vaccine and PrEP Hesitancy Among Individuals Living in Mississippi: A Qualitative Study.

Trisha Arnold, Andrew P Barnett, Kayla K Giorlando, Avery Leigland, Courtney Sims-Gomillia, Laura Whiteley, Larry K Brown

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS and behavior, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Trisha ArnoldDepartment of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, 02903, USA. trisha_arnold@brown.edu.ORCID http://orcid.org/0000-0003-3556-5717
Andrew P BarnettDepartment of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, 02903, USA.
Kayla K GiorlandoDepartment of Psychiatry, Rhode Island Hospital, One Hoppin Street Coro West, 204, Providence, Rhode, RI, 02903, USA.
Avery LeiglandDepartment of Psychiatry, Rhode Island Hospital, One Hoppin Street Coro West, 204, Providence, Rhode, RI, 02903, USA.
Courtney Sims-GomilliaDepartment of Population Health Science, University of Mississippi Medical Center, Jackson, MS, 39216, USA.
Laura WhiteleyDepartment of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, 02903, USA.
Larry K BrownDepartment of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, 02903, USA.
Brown University · USRhode Island Hospital · USUniversity of Mississippi Medical Center · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI JOSEPH W HOGAN · 1998 to 2026
$51.7M
Training in Child/Adolescent Biobehavioral HIV ResearchT32MH078788 · NIMH · RHODE ISLAND HOSPITAL · PI LARRY K BROWN · 2007 to 2026
$6.2M
Telemedicine for PrEP throughout Mississippi (Tele-PrEP-MS)R34MH115744 · NIMH · RHODE ISLAND HOSPITAL · PI BROWN, LARRY K, MENA, LEANDRO ANTONIO · 2018 to 2020
$1.3M
Improving HIV Prevention Through a Psychological Flexibility-Based ApproachK23MH124539 · NIMH · RHODE ISLAND HOSPITAL · PI ARNOLD, TRISHA · 2021 to 2025
$969k
NIAID NIH HHS P30 AI042853NIMH NIH HHS K23 MH124539NIMH NIH HHS K23MH124539-01A1NIMH NIH HHS L30 MH123946NIMH NIH HHS R34 MH115744NIMH NIH HHS T32 MH078788NIMH NIH HHS T32MH078788
6 · The paper itself

Abstract

Mississippi (MS) trails behind other states in both pre-exposure prophylaxis (PrEP) and COVID-19 vaccine uptake. This study investigated similarities in willingness to receive the COVID-19 vaccine and use PrEP. Semi-structured interviews were conducted between April 2021 and January 2022 with 15 clinical staff and 49 PrEP-eligible patients living in MS. Reflexive thematic analysis was conducted. Overall, 51% of patients were on PrEP, and 67% received the COVID-19 vaccine. Among PrEP users, 64% had received the vaccine. Participants reported similar hesitations (efficacy, side effects, and no perceived risk) and reasons for use (health autonomy and protecting themselves and others) regarding PrEP and the COVID-19 vaccine. Taking PrEP did not increase the likelihood of getting the COVID-19 vaccine, thus engaging in one prevention behavior does not lead to engaging in other prevention behaviors. However, results indicated commonalities in hesitancy and motivators to utilize both preventive measures. Future prevention and implementation efforts can be informed by these commonalities.

Indexed as

COVID-19HIV InfectionsCOVID-19 VaccinesHumansMississippiQualitative ResearchCOVID-19 VaccinesCOVID-19HIVPre-exposure prophylaxis (PrEP)Vaccine Hesitancy

Identifiers

PMID37071335
PMCPMC10112324
OpenAlexW4366234663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.